key: cord-0987568-kzuzvraa authors: Meyer Sauteur, Patrick M.; Kleger, Gian-Reto; Albrich, Werner C. title: ARDS during the COVID-19 pandemic: not only SARS-CoV-2 date: 2021-01-01 journal: New Microbes New Infect DOI: 10.1016/j.nmni.2020.100836 sha: afcd8c584b023c109f00bd351ea4b43c2f7264e4 doc_id: 987568 cord_uid: kzuzvraa A previously healthy 30-year-old woman developed severe ARDS at the beginning of the COVID-19 pandemic. SARS-CoV-2 infection was suspected, but testing was negative. Mycoplasma pneumoniae was detected by PCR in bronchoalveolar lavage fluid and blood. This case illustrates that M. pneumoniae infection can progress to septicemia and ARDS with severe respiratory failure in young healthy adults. damage [11] . M. pneumoniae septicemia in our patient may have triggered massive cell-mediated immune responses resulting in ARDS [11] [12] [13] . Mycoplasma pneumoniae ARDS manifests after an interval of 1-3 weeks from onset of respiratory symptoms [5, 6, 8] , which coincides with the timing of acquired immunity and further suggests that M. pneumoniae ARDS may represent an immune-mediated complication [5] [6] [7] [8] [9] . This hypothesis could also be the explanation for the favorable response to corticosteroid treatment observed in some M. pneumoniae ARDS cases [6] [7] [8] . Our case further highlights that in addition to PCR (in BALF and/or blood) the measurement of M. pneumoniae-specific ASCs can help confirm M. pneumoniae etiology in ARDS. Mycoplasma pneumoniae-specific ASCs are short-lived and associated with clinical disease [4] . We recently demonstrated that M. pneumoniae- Pathogenesis of COVID-19-induced ARDS: implications for an ageing population Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR Diagnosis of Mycoplasma pneumoniae pneumonia with measurement of specific antibody-secreting cells Circulating antibody-secreting cell response during Mycoplasma pneumoniae childhood pneumonia Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers Acute respiratory distress syndrome related to Mycoplasma pneumoniae infection Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit Adult respiratory distress syndrome associated with Mycoplasma pneumoniae infection Is Mycoplasma pneumoniae adherence to erythrocytes a factor in extrapulmonary dissemination? Fatal outcomes in family transmission of Mycoplasma pneumoniae Mycoplasma pneumoniae and its role as a human pathogen Mycoplasma pneumoniae-specific IFN-g-producing CD4 + effector-memory T cells correlate with pulmonary disease Improved diagnostics help to identify clinical features and biomarkers that predict Mycoplasma pneumoniae community-acquired pneumonia in children A. patient care and/or diagnostic work up A drafting the manuscript All authors critically reviewing the manuscript No funding to disclose. None. Informed consent has been obtained in writing.